Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Methods of preparing and purifying 9-nitro-20-camptothecin

a technology of nitro-20-camptothecin and purification method, which is applied in the field of preparing and purifying 9nitro-20-camptothecin, can solve the problems of further decrease of 9nc yield and 60% yield, and achieve the effect of increasing the yield of 9-nitrocamptothecin

Inactive Publication Date: 2004-01-27
THE STEHLIN FOUND FOR CANCER RES
View PDF7 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

A feature of the present invention is to provide a method for the preparation of 9-nitrocamptothecin which preferably provides an increase in the yield of 9-nitrocamptothecin.

Problems solved by technology

Further, this procedure results in unwanted byproducts such as the inactive isomer, 12-nitrocamptothecin (12NC), in a ratio of about 1 to 3 of 9NC to 12NC.
The unwanted 12NC, unfortunately, is the major product and accounts for about 60% of the yield.
Because of the low yield of the 9NC and the numerous byproducts, the process of separating and purifying the 9NC is time consuming and costly and leads to a further decrease in the yield of 9NC.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of preparing and purifying 9-nitro-20-camptothecin
  • Methods of preparing and purifying 9-nitro-20-camptothecin
  • Methods of preparing and purifying 9-nitro-20-camptothecin

Examples

Experimental program
Comparison scheme
Effect test

example 1

Reaction of Camptothecin With KNO.sub.3 in Acetic Acid

To 30 ml acetic acid in a 100 ml round-bottomed flask equipped with a magnetic stirrer were added 0.50 g (0.0014 mol) 20(S)-camptothecin and 0.50 g KNO.sub.3 (0.0050 mol). The mixture was stirred at room temperature for 24 hours and poured onto 500 ml ice-water in several portions while stirring. The suspension was extracted three times with 200 ml methylene chloride each time (200 ml.times.3). The combined extracts were dried over 200 g anhydrous sodium sulfate for 6 hours. After removal of methylene chloride by a rotary evaporator, the residue was refluxed in petroleum ether for 4 hours. After filtration and drying in air for 4 hours the product obtained was a gray white powder. HPLC analysis showed no nitration indicative of camptothecin with KNO.sub.3 in acetic acid. The starting camptothecin was recovered 100% (Table 1).

example 2

Reaction of Camptothecin With KNO.sub.3 in Acetic Anhydride

Camptothecin was nitrated and worked-up in the same manner as the reaction in Example 1. The HPLC analysis of the reaction product showed 100% recovery of the starting camptothecin (Table 1).

example 3

Reaction of Camptothecin With KNO.sub.3 in Trifluoroacetic Anhydride

Camptothecin was nitrated and work-up in the same manner as in Example 1. The HPLC analysis data for the reaction mixture is shown in Table 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A method is disclosed for the preparation of 9-nitrocamptothecin which involves reacting 20-camptothecin with at least one inorganic nitrate salt and at least one acid effective in catalyzing the formation of a nitronium ion, where the reaction occurs at a temperature and for a time sufficient to form the 9-nitrocamptothecin. Also, methods of further purifying the 9-nitrocamptothecin by column chromatography or by reprecipitation is also disclosed.

Description

BACKGROUND OF THE INVENTION1. Field of the InventionThe present invention relates to method of preparing and purifying 9-nitro-20-camptothecin (9NC).2. Description of Related Art9-nitro-20(S)-camptothecin has shown great promise in treating certain types of cancer. The water-insoluble 9-nitro-20(S)-camptothecin has been studied both in vitro and in vivo and 9-nitro-20(S)-camptothecin is in clinical trials for certain types of cancer.Japanese Kokai Patent Application No. 59-51288 provides one method of making 9-nitro-camptothecin by treating camptothecin with a slight excess of concentrated nitric acid in concentrated sulfuric acid. However, when following this procedure, a yield of about 3% to about 7% of the 9NC product which is capable for medicinal use is obtained. Further, this procedure results in unwanted byproducts such as the inactive isomer, 12-nitrocamptothecin (12NC), in a ratio of about 1 to 3 of 9NC to 12NC. The following scheme shows the reaction from the use of nitric...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D491/22C07D491/00
CPCC07D491/22
Inventor CAO, ZHISONG
Owner THE STEHLIN FOUND FOR CANCER RES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com